Neomadol Injection 50mg (Tramadol Hydrochloride)
Tramadol Hydrochloride 50mg
Prescription medication
Kooju Pharmaceutical Co., Ltd.
MFDS item code 201607396 · Notified 2016.12.30 · Insurance code 669804851
This product's status changed to Approval withdrawn on 2026.01.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of moderate to severe acute and chronic pain (including cancer pain) and pain after diagnostic procedures or surgery
This medication is effectively used for severe and moderate acute and chronic pain, particularly pain caused by various cancers and pain occurring after diagnosis and surgery.
The dose of this medicine should be adjusted according to the intensity of the patient's pain and clinical response. In general, use the lowest dose that provides pain relief. Inject 50-100mg of tramadol hydrochloride intravenously or intramuscularly per dose, then repeat every 4-5 hours as needed. A maximum of 400mg may be administered per day. No dose adjustment is necessary in patients 75 years of age or younger with no clinically confirmed hepatic or renal impairment. In patients older than 75 years, elimination of this medicine may be delayed; adjust the dosing interval as needed. In patients with renal or hepatic impairment, elimination of this medicine may be delayed; therefore, consider extending the dosing interval in these patients.
Caution is advised as overdose of this medication can lead to seizures. This drug should only be used when absolutely necessary in patients with a history of seizures or those at risk of seizures. Long-term use can lead to psychological and physical dependence; thus, it should only be used for a short period under strict supervision in patients with a history of substance abuse or dependence. Using this drug with alcohol or central nervous system depressants increases the risk of severe sedation, respiratory depression, and coma, so co-administration should be avoided or approached with caution. Patients with fast metabolism genetically may have elevated blood concentrations, increasing the risk of respiratory depression, necessitating dose adjustments and monitoring. It is advisable not to use this medication in children under 12 years or adolescents under 18 years with certain surgeries. This medication should not be administered to patients who have acute alcohol intoxication, severe respiratory depression, head trauma, or those on MAO inhibitors. Patients with severe liver or kidney impairment, pregnant women, and breastfeeding mothers are also recommended not to use this medication. Patients should avoid driving or operating dangerous machinery as drowsiness, dizziness, or nausea may occur during medication use. Additionally, discontinuing this drug abruptly can cause withdrawal symptoms; therefore, doses should be tapered off gradually under medical supervision. Due to many possible interactions with other medications that can enhance central nervous system depression, consultation with a physician or pharmacist is essential. During pregnancy or breastfeeding, this medication should not be used due to potential effects on the fetus or newborn. Elderly patients may require dose adjustments due to the potential for increased blood concentrations. In the event of an overdose, severe respiratory depression and seizures may occur, necessitating immediate emergency treatment; naloxone can be used as an antidote. This medication should be stored out of reach of children and kept in the original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air exposure and kept at room temperature between 1 degrees to 30 degrees Celsius. Storing it this way will maintain the medication's effectiveness and prevent degradation.
Colorless, transparent solution filled in a colorless transparent ampoule
50 ampoules/box [(ampoule (1mL))]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tramadol Hydrochloride 50mg
Prescription medication
Kooju Pharmaceutical Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
(Yuhan Corporation)

Tramadol Hydrochloride 50mg
Hard capsule · Prescription medication
Yuhan Corporation
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Hanol BioPharma Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 100mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Ilseong IS Co., Ltd.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.